DOI:
10.1055/s-00032260
Digestive Disease Interventions
LinksClose Window
References
Fitzgerald RC, di Pietro M, O'Donovan M. et al; BEST3 Trial Team.
Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial.
Lancet 2020;
396 (10247): 333-344
We do not assume any responsibility for the contents of the web pages of other providers.